CyM Biotech is a pioneering biotechnology company focused on revolutionizing synthetic biology for enhanced healthcare solutions. Specializing in designing and developing engineered cells and microorganisms, it aims to address critical medical challenges. The company leverages cutting-edge gene editing technologies to create innovative therapeutic options. Based in Portugal, CyM Biotech is at the forefront of advancing personalized medicine and sustainable bio-based production. Through their expertise, they strive to make significant contributions to the life sciences and global health landscape.